China Shineway Pharmaceutical Group Limited
HKEx Stock Code: 02877 Chinese
Financial Reports
Interim Report  2020 2020
Interim Report
 
More  
Monthly Newsflash
2021 Feb Newsflash 2021
Feb Newsflash
 
More  
Financial Calendar
 
Ex-Dividend Day
4 June 2020
 
  More
  China Shineway Pharmaceutical Group Limited is the largest Chinese medicine injection and soft capsule manufacturer in the PRC. Our shares are listed on the Main Board of Hong Kong Stock Exchange. Shineway is one of the Hang Seng Composite Index constituents and is named by Forbes Magazine as Asia's Best 200 Under a Billion.

Our products are primarily categorized into three major types: injection, soft capsule and granule, targeting three market segments with high growth potential, namely the middle and old aged, anti-viral and children, and are marketed under the "SHINEWAY" brand - a China Famous Trademark.
Latest News
Announcements and Notices - CHANGE OF ADDRESS OF SHARE REGISTRAR AND TRANSFER AGENT IN THE CAYMAN ISLANDS   26 Feb 2021
Announcements and Notices - SUPPLEMENTAL ANNOUNCEMENT CONNECTED TRANSACTIONS AND CONTINUING CONNECTED TRANSACTIONS   18 Dec 2020
Announcements and Notices - CONNECTED TRANSACTIONS AND CONTINUING CONNECTED TRANSACTIONS   17 Dec 2020
Product Highlight
 
Qingkailing Soft Capsules
Clearing away heat and toxins...
 
  More  
Related Links
Email Alerts
Industry Regulations
Shineway's China Website Related Website of Pharmaceutical Industry